| Start date | Project | acronym | role | funding | partners |
|---|
| 2008-09-01 | Nanoparticles for therapy and diagnosis of Alzheimer disease |
NAD | participant | 10.921.350 | 19 |
| 2008-09-01 | An integrated study on three novel regulatory hubs in megakaryocytes and platelets, discovered as risk genes for myocardial infarction by a genome-wide association and platelet systems biology study |
NETSIM | participant | 2.851.384 | 10 |
| 2008-06-01 | IBD: proteases offer new targets for drug discovery |
IPODD | participant | 2.999.250 | 12 |
| 2008-02-01 | Next generation HIV-1 immunogens inducing broadly reactive neutralising antibodies |
NGIN | participant | 7.534.742 | 17 |
| 2008-02-01 | Occupational Health and Safety Economics |
ECOSH | participant | 210.574 | 5 |
| 2008-01-01 | Molecular and cellular investigation of neuron-astroglia interactions: Understanding brain function and dysfunction |
NEUROGLIA | participant | 2.988.450 | 8 |
| 2007-07-01 | Pathogenesis and identification of predictive factors of TB-IRIS in HIV patients under HAART |
TBIRIS | participant | 2.475.482 | 7 |
| 2007-07-01 | Contribution of molecular epidemiology and host-pathogen genomics to understand Chlamydial trachomatis disease |
EPIGENCHLAMYDIA | participant | 450.000 | 19 |
| 2007-04-01 | Evolution of the Protein-Interaction Networks: the SH3 network in Yeast |
PENELOPE | participant | 2.900.000 | 7 |
| 2007-02-01 | European AIDS treatment Network |
NEAT | participant | 12.500.000 | 41 |
| 2007-01-15 | Pre-clinical studies towards an affordable, safe and efficacious two-component paediatric malaria vaccine |
PRIBOMAL | participant | 2.345.358 | 6 |
| 2007-01-01 | Development of an effective RNA interference-based anti-HIV-1 therapy using an SV40-derived gene transfer vector |
HIVSTOP | participant | 2.250.000 | 4 |
| 2007-01-01 | Immune response to respiratory virus infections and vaccination in elderly |
RESPVIRUSES | participant | 1.770.361 | 8 |
| 2007-01-01 | Applied Genomic strategies for treatment and prevention of cardiovascular death in Uraemia and end stage renal disease |
GENECURE | participant | 2.246.000 | 10 |
| 2007-01-01 | European vaccine and microbicides enterprise |
EUROPRISE | participant | 20.095.505 | 39 |
| 2006-08-01 | Improving the safety of blood and organ supply by creating the research infrastructure to monitor emerging pathogens and develop new screening tests |
BOTIA | participant | 2.091.095 | 9 |
| 2006-03-01 | Concerted action on seroconversion to AIDS and death in Europe |
CASCADE | participant | 1.700.000 | 25 |
| 2006-03-01 | The EuroSIDA Network 2005-2009. Clinical and virological outcome of patients with HIV under care in Europe |
EUROSIDA 2005-2009 | participant | 3.000.000 | 16 |
| 2005-09-01 | Global view of food allergy: opportunities to study the influence of microbial exposure |
GLOFAL | participant | 413.814 | 8 |
| 2005-06-01 | The prevalence, cost and basis of food allergy across Europe |
EUROPREVALL | participant | 14.329.838 | 68 |
| 2005-03-01 | Reprogramming the immune System for the Establishment of Tolerance |
RISET | participant | 9.781.150 | 26 |
| 2005-01-01 | Challenging the hidden HIV: understanding the block on transcriptional reactivation to eradicate infection |
HIDDEN HIV CHALLENGE | participant | 657.998 | 5 |
| 2004-06-01 | Identification of risk genes for atherothrombosis in coronary artery disease by transcriptome and proteome analysis and high throughput exon resequencing |
BLOODOMICS | participant | 8.879.154 | 14 |
| 2004-04-01 | Platform of information services for the coordination of rare disease research with various stakeholders from research, SMEs and patient organisations and the coordination of early clinical trials |
ORPHANPLATFORM | participant | 400.000 | 18 |
| 2004-04-01 | X-linked Adrenoleukodystrophy (X-ALD): pathogenesis, animal models and therapy |
X-ALD | participant | 1.800.000 | 6 |
| 2004-01-01 | Strengthen and develop scientific and technological excellence in research and therapy of leukemia (CML, AML, ALL, CLL, MDS, CMPD) by integration of the leading national leukemia networks and their interdisciplinary partner groups in Europe |
EUROPEAN LEUKEMIANET | participant | 6.000.000 | 177 |
| 2004-01-01 | Health promoting, safe seafood of high eating quality in a consumer driven fork-to-farm concept |
SEAFOODPLUS | participant | 14.399.994 | 72 |
| 2004-01-01 | European Vascular Genomics Network |
EVGN | participant | 9.000.000 | 34 |
| 2003-12-01 | 3D Genome structure and function |
3DGENOME | participant | 2.173.803 | 8 |
| 2003-01-01 | Contrast enhanced ultrasound imaging in the diagnosis and treatment of prostate cancer (contrast). |
CONTRAST | coordinator | 288.522 | 3 |
| 2003-01-01 | Risks of occupational vibration exposures |
VIBRISKS | participant | 1.591.826 | 6 |
| 2003-01-01 | Recommendations for a future instrument for the gendersensitive assessment of health research protocols by research ethics committees (recs). |
GENDER AND RECS | coordinator | 111.617 | 5 |
| 2002-12-01 | European vaccine effort against HIV/AIDS - III |
EUROVAC-III | participant | 2.500.000 | 9 |
| 2002-12-01 | Refsum's disease: diagnosis, pathology and treatment (RDDPT) |
RDDPT | coordinator | 1.065.727 | 4 |
| 2002-10-01 | Evaluation of a therapeutic vaccination strategy for hiv infection (THERAVAC) |
THERAVAC | participant | 2.379.647 | 9 |
| 2002-09-01 | Virological characterisation of primary hiv infection in the concerted action on seroconversion to aids and death in europe (CASCADE VIROLOGY) |
CASCADE VIROLOGY | participant | 528.240 | 14 |
| 2002-09-01 | Twin to twin transfusion syndrome and monochorionic twinning european network |
EURO-TWIN-2-TWIN | participant | 1.555.400 | 8 |
| 2002-09-01 | Hiv-1 reverse transcriptase inhibitor and its consequences for viral virulence |
VIRULENCE | participant | 1.299.998 | 8 |
| 2002-01-01 | Quality of life following adherence therapy for people disabled by schizophrenia and their carers (QUATRO) |
QUATRO | participant | 1.845.438 | 4 |
| 2002-01-01 | Peroxisomal diseases: elucidation of the pathogenesis and evaluation of treatments by using mouse models (MMPD) |
MMPD | participant | 995.214 | 4 |
| 2001-12-01 | European prediction of psychosis study (EPOS) |
EPOS | participant | 1.891.188 | 4 |
| 2001-12-01 | Genome-wide structural and functional analysis of sh3-mediated interactions (SH3 GENOMICS) |
SH3 GENOMICS | coordinator | 1.467.753 | 5 |
| 2001-11-01 | European vaccine effort against hiv/aids - ii |
EUROVAC-II | participant | 2.999.997 | 13 |
| 2001-10-01 | Development of standardised blood and a reference procedure for determination of aggregation of blood cells (AGGREGATION STANDARD) |
AGGREGATION STANDARD | participant | 596.000 | 4 |
| 2001-09-01 | Development and clinical study of a bioartificial liver based on reversibly immortalised human hepatocytes |
BIOARTIFICIAL LIVER | coordinator | 2.226.380 | 6 |
| 2001-09-01 | The european network for vertically acquired hepatitis c virus infection (EPHN) |
EPHN | participant | 500.000 | 43 |
| 2001-01-01 | Optical methods for medical diagnosis and monitoring of diseases |
| participant | 1.095.743 | 19 |
| 2001-01-01 | Evaluations and predictions of dermal absorption of toxic chemicals |
EDETOX | participant | 1.988.530 | 12 |
| 2000-12-01 | The eurosida network 2000-2004. clinical and virological outcome of european patients infected with hiv. |
| participant | 1.150.000 | 12 |
| 2000-11-01 | Advances in epidemetric parameters of zoonotic cutaneous leishmaniasis to validate tools for surveillance and control |
ADVANCES IN ZCL | participant | 399.931 | 4 |
European Research Ranking